Incidence of Ischemic Stroke in Seniors Not Reduced by Low-Dose Aspirin
FRIDAY, July 28, 2023 -- For healthy older adults, low-dose aspirin does not reduce the risk for ischemic stroke but is associated with an increased risk for intracranial bleeding, according to a study published online July 26 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 28, 2023 Category: Pharmaceuticals Source Type: news

Women With LVO Acute Ischemic Stroke Less Likely to Be Routed to Stroke Centers
WEDNESDAY, July 26, 2023 -- Women with large vessel occlusion (LVO) acute ischemic stroke (AIS) are less likely to be routed to comprehensive stroke centers (CSCs) compared with men, despite presenting with more significant stroke syndromes,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2023 Category: Pharmaceuticals Source Type: news

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Media News - July 24, 2023 Category: Pharmaceuticals Source Type: news

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
Partnership combines Roche ’s proven track record of successfully developing and launching innovative medicines worldwide withAlnylam ’s leadership in RNAi therapeuticsZilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressureHypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. While several therapies exist, a significant unmet need, especially for high risk patients, remains.1Basel, 24 July 2023 - Roche (SIX: RO, ROG; OT...
Source: Roche Investor Update - July 24, 2023 Category: Pharmaceuticals Source Type: news

Can Patent Foramen Ovales Cause Problems?
Discussion During fetal development, the heart primum and secundum septa grow and overlap leaving a small but important channel between the two atria. The foramen ovale is a flap valve moving blood from the right atrium into the left atrium directly and bypassing the high pressure pulmonary system. After birth and breathing air, the neonate’s lungs open up and the pulmonary vascular resistance decreases. The left atrium now has a relatively higher pressure than the right atria, and therefore pressure on the flap valve closes the foramen ovale. Usually within 6-12 months, the fusion of the primum and secundum of the f...
Source: PediatricEducation.org - July 24, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Ischemic Stroke With Supratherapeutic INR Following COVID-19 Ischemic Stroke With Supratherapeutic INR Following COVID-19
This case report highlights the potential for thromboembolic events in patients with COVID-19 infection, even when receiving therapeutic anticoagulation therapy.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Warning Stroke: What It Is And Symptoms To Look For
Many people who experience a transient ischemic attack will go on to have a stroke within 90 days. Here are the red flags. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - July 20, 2023 Category: Consumer Health News Source Type: news

Positive Phase III results for Roche ’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis
Phase III OCARINA II trial met primary and secondary endpointsOCREVUS twice a year, 10-minute injection has the potential to further improve the treatment experience and expand OCREVUS usage in MS centres with IV capacity limitations or without IV infrastructureOCREVUS remains the first and only therapy approved for both RMS and PPMS, and more than 300,000 people have been treated globallyBasel, 13 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III OCARINA II trial evaluating OCREVUS ® (ocrelizumab) as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in...
Source: Roche Media News - July 13, 2023 Category: Pharmaceuticals Source Type: news

Positive Phase III results for Roche ’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis
Phase III OCARINA II trial met primary and secondary endpointsOCREVUS twice a year, 10-minute injection has the potential to further improve the treatment experience and expand OCREVUS usage in MS centres with IV capacity limitations or without IV infrastructureOCREVUS remains the first and only therapy approved for both RMS and PPMS, and more than 300,000 people have been treated globallyBasel, 13 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III OCARINA II trial evaluating OCREVUS ® (ocrelizumab) as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in...
Source: Roche Investor Update - July 13, 2023 Category: Pharmaceuticals Source Type: news

Ticagrelor-Acetylsalicylic Acid More Beneficial for Obese With Minor Stroke, TIA
MONDAY, July 10, 2023 -- For patients with minor stroke or transient ischemic attack (TIA) who carry the CYP2C19 loss-of-function allele, those with obesity receive more clinical benefit from ticagrelor-acetylsalicylic acid (ASA) than... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2023 Category: Pharmaceuticals Source Type: news

Icometrix secures CPT code for AI brain MRI software
Icometrix has secured a current procedural terminology (CPT) code for its AI-relate...Read more on AuntMinnie.comRelated Reading: Michael J. Fox Foundation awards grant to Icometrix AI improves speed, quality of neuroimaging Aidoc and Icometrix pair up for stroke care Icometrix launches AI software for ischemic stroke Icometrix names new chief commercial officer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 5, 2023 Category: Radiology Source Type: news

Intense Exercise May Be Risky in Moderate to Severe Stenosis Intense Exercise May Be Risky in Moderate to Severe Stenosis
Exercise is usually beneficial for cardiovascular health, but this study suggests it may raise the ischemic stroke risk among those with moderate to severe carotid stenosis.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 30, 2023 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news

Noninvasive Brain Stimulation Promising for Acute Stroke Noninvasive Brain Stimulation Promising for Acute Stroke
Noninvasive brain stimulation may help salvage penumbra affected by acute ischemic stroke, promising results from a new pilot study suggest.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 30, 2023 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news

Women With Migraine Have Higher Risk for Heart Attack, Hemorrhagic Stroke
TUESDAY, June 13, 2023 -- The risk for ischemic stroke in individuals with migraine is similar for men and women, while the risk for myocardial infarction (MI) and hemorrhagic stroke is only higher in women with migraine, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news

Incomplete ED Neurovascular Imaging Tied to Higher Odds of 90-Day Stroke
TUESDAY, June 13, 2023 -- Emergency department visits for transient ischemic attack (TIA) with incomplete neurovascular imaging are associated with higher odds of subsequent stroke within 90 days, according to a study published online May 31 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news